Tissue Regeneration Systems Revenue and Competitors

Detroit, MI USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Tissue Regeneration Systems's estimated annual revenue is currently $775k per year.(i)
  • Tissue Regeneration Systems's estimated revenue per employee is $155,000

Employee Data

  • Tissue Regeneration Systems has 5 Employees.(i)
  • Tissue Regeneration Systems grew their employee count by 25% last year.

Tissue Regeneration Systems's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.9M120%N/AN/A
#2
$2.6M34-56%$31.2MN/A
#3
$0.8M5-44%N/AN/A
#4
$1.9M24100%N/AN/A
#5
$6M39-11%N/AN/A
#6
$4M26-33%N/AN/A
#7
$1.9M120%N/AN/A
#8
$0.8M525%N/AN/A
#9
$14.6M948%N/AN/A
#10
$3.4M225%N/AN/A
Add Company

What Is Tissue Regeneration Systems?

Tissue Regeneration Systemsâ„¢ (TRSâ„¢) is a start-up medical device company commercializing a breakthrough skeletal reconstruction and bone regeneration technology platform licensed from the Universities of Michigan and Wisconsin. Our technology addresses a broad range of clinical applications, and has been validated by comprehensive University, NIH and company-sponsored research initiatives spanning a period of well over a decade. NOVEL 3D PRINTED RESORBABLE SCAFFOLDS TRS has a proven capability to fabricate complex, patient specific, load- bearing resorbable implant solutions using 3D printing methods. UNIQUE BIOACTIVE MINERAL COATING Our proprietary mineral coating, Affinityâ„¢, exhibits unique bioactive properties that can be applied to our resorbable scaffolds, as well as to conventional orthopedic and spine implants. The Affinity morphology is a plate-like nanostructure, which mimics the mineral structure of native bone, and modulates the biologic environment in a manner not previously exhibited by other implant coatings. SCALABLE FDA COMPLIANT MANUFACTURING TRS has established a fully independent, FDA-compliant manufacturing facility with a certified cleanroom. Our operation can support commercial product volumes. FDA CLEARANCE Both our 3D printed resorbable scaffold technology and our Affinity mineral coating have received FDA 510(k) clearance. STRONG INTELLECTUAL PROPERTY AND TRADE SECRET POSITION TRS has an extensive patent portfolio and has also accumulated a number of important trade secrets in perfecting our technology and fabrication methods. Together, this creates meaningful protection and exclusivity for our technology platform.

keywords:N/A

N/A

Total Funding

5

Number of Employees

$775k

Revenue (est)

25%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M50%N/A
#2
$0.4M50%N/A
#3
N/A5-84%N/A
#4
$0.4M50%N/A
#5
$0.4M60%N/A